ORTX(Delisted)
Orchard Therapeutics·NASDAQ
--
--(--)
ORTX fundamentals
Orchard Therapeutics (ORTX) released its earnings on May 28, 2019: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
May 28, 2019
EPS
Revenue
Revenue & Expenses
ORTX has released its 2023 Q3 earnings report, with revenue of 6.30M, reflecting a YoY change of 9.09%, and net profit of -35.32M, showing a YoY change of 25.75%. The Sankey diagram below clearly presents ORTX's revenue sources and cost distribution.
Key Indicators
Orchard Therapeutics (ORTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Orchard Therapeutics (ORTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Orchard Therapeutics (ORTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Orchard Therapeutics (ORTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Orchard Therapeutics (ORTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Orchard Therapeutics (ORTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
